Sign in

CIK 0000882796 · Large accelerated filer

BIOCRYST PHARMACEUTICALS INC

Sign in to watch
Ticker
BCRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
621413174
Phone
919-859-1302
Business address
4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
  1. S-8 Other Securities Offered to Employees in Benefit Plans
  2. 10-Q Report Quarterly Report
  3. 8-K Event Results of operations · Regulation FD disclosure
  4. 4 Open-market sale Director sold 8,600 shares at $6.32 ($54,352)
  5. 144 Insider Sale of Securities
  6. 4 Open-market sale Director sold 4,689 shares at $6.00 ($28,134)
  7. 144 Insider Sale of Securities
  8. 4 Grant or award Director acquired 6,820 shares (grant or award)
  9. 4 Grant or award Director acquired 6,820 shares (grant or award)
  10. 4 Grant or award Director acquired 6,820 shares (grant or award)
  11. 4 Grant or award Director acquired 6,820 shares (grant or award)
  12. 4 Grant or award Director acquired 6,820 shares (grant or award)
  13. 4 Open-market sale Director sold 6,698 shares at $6.11 ($40,925)
  14. 4 Grant or award Director acquired 6,820 shares (grant or award)
  15. 4 Grant or award Director acquired 6,820 shares (grant or award)
  16. 4 Grant or award Director acquired 6,820 shares (grant or award)
  17. 144 Insider Sale of Securities
  18. 8-K Event Executive or director change · Shareholder vote results
  19. 4 Grant or award Director acquired 870 shares (grant or award)
  20. 4 Grant or award Director acquired 870 shares (grant or award)

Page 10 of 99 · 1,967 filings